Web Analytics

Investor Profile

Viking Global Investors

Viking Global Investors United States - Greenwich, Connecticut
INVESTOR

1 Disclosed Funding Rounds $401,000,000
27 Participating Investments




Viking Global Investors LP (“Viking”) is a global investment firm founded in 1999. We employ a fundamentals-driven investment approach to managing over $40 billion of capital across long/sho

Invested In

Company Date Round Raised
  ID.me April, 12 ,2023 Series D $132,000,000
  Arctic Wolf October, 06 ,2022 Unknown $401,000,000
  Abdera Therapeutics April, 24 ,2023 Series B $142,000,000
  Ensoma February, 06 ,2023 Series B $85,000,000
  Solarea Bio May, 09 ,2023 Series B $15,000,000
  AlphaSense June, 15 ,2022 Series D $225,000,000
  Pragma Bio March, 27 ,2023 Unknown $10,000,000
  Lightmatter June, 01 ,2023 Series C $154,000,000
  Global Processing Services January, 13 ,2022 Unknown $100,000,000
  DermBiont, Inc. October, 25 ,2023 Series B $35,200,000
  ID.me April, 12 ,2023 Series D $132,000,000
  Triveni Bio October, 27 ,2023 Series A $92,000,000
  Abdera Therapeutics April, 24 ,2023 Series B $142,000,000
  HI-Bio January, 05 ,2024 Series B $95,000,000
  Solarea Bio May, 09 ,2023 Series B $15,000,000
  Valsoft Corporation January, 22 ,2024 Unknown $170,000,000
  Lightmatter June, 01 ,2023 Series C $154,000,000
  Sionna Therapeutics March, 07 ,2024 Series C $182,000,000
  DermBiont, Inc. October, 25 ,2023 Series B $35,200,000
  Antheia, Inc. July, 23 ,2024 Unknown $17,000,000
  Triveni Bio October, 27 ,2023 Series A $92,000,000
  Metsera November, 14 ,2024 Series B $215,000,000
  HI-Bio January, 05 ,2024 Series B $95,000,000
  Valsoft Corporation January, 22 ,2024 Unknown $170,000,000
  Sionna Therapeutics March, 07 ,2024 Series C $182,000,000
  Antheia, Inc. July, 23 ,2024 Unknown $17,000,000
  Metsera November, 14 ,2024 Series B $215,000,000